In our newest review article “Starmerella bombicola, an industrially relevant, yet fundamentally underexplored yeast”, the focus is laid on the discovery, taxonomy, habitat, cellular characteristics, biochemistry and genetics of this non-pathogenic yeast. You can find the minireview in FEMS Yeast Research…
ICGEB course Ecuador: InBio.be present!
From 18th to 22nd June 2018, an ICGEB course about “Development of surface active compounds from microorganisms: production, characterization and evaluation” took place in (Guayaquil) Ecuador. The patented technology platform around innovative and new glycolipids developed at InBio.be was presented by dr. Sophie Roelants.
Check out our book chapter in ‘Synthetic Biology: Methods and Protocols’
Our new book chapter ‘Transformation of an Exotic Yeast Species into a Platform Organism: A Case Study for Engineering Glycolipid Production in the Yeast Starmerella bombicola’ is published in ‘Synthetic biology: Methods and protocols’. In this chapter, a step-by-step approach on how to transform…
Column: Gestuurde samenleving
Click here to read Prof. Wim Soetaert ‘s last column, published in Petrochem 05-2018.
Regulatory approval of the first human milk oligosaccharide (HMO) in Europe
On the 27 st of March 2018, DuPont Nutrition & Health and Inbiose NV celebrated the regulatory approval of their first human milk oligosaccharide (HMO) ingredient for infant formula in the European market: 2’-fucosyllactose (2’-FL)! Human milk oligosaccharides, complex…